Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CapMan to publish its 1 – 3 2024 Interim Report on Friday 3 May 2024

CapMan Plc press release                              26 April 2024 at 10:30 a.m. EEST CapMan to publish its 1 – 3 2024 Interim Report on Friday 3 May 2024 CapMan will publish its interim report for the period 1 January–31 March 2024 on Friday 3 May 2024 around 8.00 a.m. EEST. The company will present the results for the review period over a webcast press conference starting at 9.30 a.m. EEST accessible at https://capman.videosync.fi/q1-2024. The conference will be held in English. The report and presentation material will be available at CapMan’s website after the publication (

Major shareholder announcement

Company announcement No. 557, 2024In accordance with Section 30 of the Capital Markets Act it is hereby announced that Nordea Funds Ltd, Finland, yesterday informed H+H International A/S that as per 22 April 2024 Nordea Funds Ltd. increased its holding of shares in H+H International A/S to a total of 1,707,348 shares, equal to 10.34% of the total share capital and of the total voting rights in H+H International A/S, thus exceeding the major shareholder threshold of 10% in Section 38 of the Capital Markets Act.

Invitation – presentation of interim report Q1 2024

KlaraBo will publish its interim report for Q1 2024 at 8:00 a.m. (CEST) on Friday May 3rd and will hold a webcast presentation and conference call at 09:00 a.m. (CEST) the same day. KlaraBo’s CEO Andreas Morfiadakis and CFO Per Holmqvist will present the report and answer questions. The presentation will be held in Swedish. Conference call and webcast presentationTime: 09.00 a.m. (CEST) on Friday May 3rd, 2024 Link to webcast below. Via the webcast you can ask questions in writing.KlaraBo Q1 Report 2024 (financialhearings.com) 

NIB in Q1: Strong financial performance continues

During the first three months of 2024, the Nordic Investment Bank (NIB) signed close to EUR 1 billion in new lending and disbursed EUR 643 million. The lending was distributed across various sectors and countries, including the Bank’s first disbursements to InvestEU loans. On 22 March, the annual meeting of the Board of Governors of NIB was held in Tallinn. The Governors approved the Bank’s audited financial statements for 2023 and the dividend payment of EUR 63 million to the Nordic and Baltic member countries. The Governors also issued a statement 

Publication of Raute Corporation’s Q1 2024 Interim Report and invitation to a briefing

RAUTE CORPORATION, INVESTOR NEWS, 26 APRIL 2024, AT 10:00 A.M. Publication of Raute Corporation’s Q1 2024 Interim Report and invitation to a briefingRaute Corporation will publish its Interim Report for January 1−March 31, 2024 (3 months) on Friday, May 3, 2024, at about 9 a.m. A briefing for analysts, investors and the media will be organized on the same day May 3, 2024, at 2:00−3:00 p.m. Venue place: Scandic Simonkenttä Hotel, Simonkatu 9, Helsinki. Please inform of your participation in the briefing at the latest on Tuesday, April 30, 2024, to Raute Corporation, Elina

Successful educational CST course held with Malteser Germany based on the CST-Assistant

Copenhagen, Denmark, 26 April 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · The value of the CST-Assistant v1.0 in facilitating easier CST implementation, saving preparation time and supporting therapeutic delivery was confirmed in the course · Integrating the CST-Assistant in the German CST education is an important means for Brain+ to build user adoption and demand for the product · After the course, Brain+ has agreed to provide Malteser with free access to the CST-Assistant to support CST implementation in a test phase against data and user feedback · While Brain+

SCA to increase kraftliner prices by €60 per tonne

SCA increases the prices on brown and white kraftliner in Europe by €60 per tonne. The new price is valid from June 1, 2024.- There's a growing demand for kraftliner in the market, well-supported by a balanced supply chain. We need to address the ongoing cost challenges effectively to ensure a continuous supply," remarks Mikael Frölander, Vice President of Marketing and Sales at SCA Containerboard.  For further information, please contact: Mikael Frölander, VP Sales & Marketing SCA Containerboard, tel. +46 70 616 81 10SCA Media Relations, tel. +46 60 19 33 01

Interim Report Q1 2024 (January - March)

January – March 2024- Revenue MSEK 125 (113)- Order intake and Procurement Awards MSEK 318 (90)- Operating profit (EBITDA) MSEK 3.7 (1.5)- Operating profit (EBIT) MSEK -6.9 (-8.6)- Total Comprehensive income MSEK 25.0 (0.5)- Earnings per share, before and after dilution (SEK) -0.45 (-1.21)- Cash flow from operating activities MSEK 55.0 (-7.8)Comments from the CEO Delivering on our ambitionWe realised a strong order intake this quarter, one of the highest Q1 order intakes in our history of SEK 318 (90) million including procurement awards. Our sales team in the USA is

Interim report January – March 2024

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value rose to SEK 204 per share, compared with SEK 198 per share at the start of the year. This is an increase of 2.8 per cent. By comparison, the Stockholm Stock Exchange’s Total Return Index (SIXRX) increased by 7.9 per cent. The net asset value was SEK 198 per share at 25 April.[1] · The total return on the Latour share was 7.3 per cent measured against the SIXRX, which rose 7.9 per cent. INDUSTRIAL OPERATIONS · The industrial operations’ order intake fell by 1 per cent to SEK 6,264 m (6,320 m). Adjusted for foreign

Implantica publishes Annual Report 2023

Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company’s website.“Implantica had a very successful and busy 2023. We are well advanced in convincing the surgical community that RefluxStop™ is the upcoming standard of care. The market for RefluxStop™ is truly massive, with 1 billion sufferers, and more than 400 million acid reflux sufferers unable to find relief from medicine. In Europe, we are clearly gaining traction with the region’s

Board members’ operational roles come to an end

As planned, on 30 April Studsvik´s board member Agneta Nestenborg will leave the operational role she has held since November 2023 within the Fuel and Materials Technology business area. On May 1 she will be succeeded by Niklas Lindberg in the role of head of production operations including project deliveries and plant operation. Niklas joins us from his most recent position as senior business developer at Novotech, having worked for most of his career within global corporations and startups. President and CEO Camilla Hoflund remains in the role of Business Area President Fuel and

Vital e-mobility conference to be held in Gothenburg, Sweden

The Electric Vehicle Symposium, EVS, is returning to Europe next year. Gothenburg will host the global e-mobility event EVS38, from June 15th to 18th, 2025. As the birthplace for brands like Volvo, Polestar and Heart Aerospace, the city is pivotal in a complete value chain for mobility and transportation, and home for a wide range of innovative companies at the forefront of e-mobility.The Electric Vehicle Symposium & Exhibition, EVS, is the leading global event for the transformation to electrification in all modes of transport. The symposium brings together manufacturers, authorities, and

SAS files monthly operating reports with U.S. court and announces certain financial information for the Group

SAS AB (“SAS” or the “Company”) and each of its subsidiaries that are subject to the voluntary chapter 11 process in the U.S. will shortly file monthly operating reports, containing certain financial information for the period of November 1, 2023 to March 31, 2024 with the U.S. Bankruptcy Court for the Southern District of New York (the “Court”). All SAS companies that are subject to the voluntary chapter 11 process are each required to file operating reports with the Court on a monthly basis. The financial information contained in the monthly operating reports includes items such as cash

Interim Report January – March 2024

SOFT ORDER INTAKE – MARKET OUTLOOK REMAINS GOODFinancial development first quarter 2024 · Net sales decreased by 18% to SEK 232 million (283). · The gross margin was 48.4% (45.3). · Adjusted EBITDA amounted to SEK 8.7 million (34.0), equivalent to an adjusted operating margin of 3.7% (12.0). · Operating profit (EBIT) amounted to SEK -6.8 million (21.7), corresponding to an operating margin of -2.9% (7.7). · Order intake decreased by 37% to SEK 215 million (343). · The order backlog as of March 31, 2024 increased by 2.5% to SEK 1,311 million compared with the same date in

The last day of trading with the warrants of series TO4 in PEPTONIC medical AB is today, April 26, 2024

NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA, CANADA, OR IN ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE FURTHER ACTIONS BEYOND THOSE REQUIRED BY SWEDISH LAW. Today, April 26, 2024, is the last day of trading with the warrants of series TO4 (“Warrants”) in PEPTONIC medical AB (“Peptonic” or the “Company”). The exercise period for the Warrants runs up to and including May 1, 2024. Each Warrant gives the owner the

Tecnotree Corporation Interim Report 1 Jan – 31 Mar 2024 (unaudited)

Tecnotree Corporation Stock Exchange Release 26 April 2024 at 9.00 EESTOn-track revenue growth, improved profitability while facing currency exchange fluctuations First quarter (January – March 2024) · Net sales increased 4.7% to EUR 16.3 (15.5) million. · Net sales constant currency increased  35% EUR 21.6 (16.0) million · Operating result increased 22.3% to EUR 4.4 (3.6) million. · Foreign exchange losses increased 80.3% to EUR 1.7 (1.0) million. · Result for the period decreased by 10.4% to EUR 1.6 (1.8) million. · Gross cash inflow from operating activities EUR 1.

ARTE COLLECTUM I AB (PUBL) PUBLISHES 2023 ANNUAL REPORT

PRESS RELEASE26 April 2024, at 08:00 – Stockholm.Arte Collectum I AB (publ)www.artecollectum.comArte Collectum I AB (publ) publishes its annual report for the year 2023 on its website artecollectum.com and as an attachment to this press release.  * * * For further information, please contact: Jonas Höglund, Chief Executive OfficerTelephone: +46 733 76 67 55E-mail: jonas.hoglund@artecollectum.com This information is such information Arte Collectum I AB (publ) is obliged to make public according to the Swedish Securities Market Act (2007:528). The information was

Aonic AB (publ) publishes annual report for 2023

Press releaseFRI, APR 26, 2024, [08.00] CEST Aonic AB (publ) has today published its annual report for the 2023 financial year on the company's website https://aonic.co/. The annual report is available on the company's website as a PDF and in European Single Electronic Format (ESEF). For further information, please contact: Paul Schempp, CEO +46 76 344 53 77 paul.schempp@aonic.co Fredrik Iversen, CFO +46 76 040 86 21 fredrik.iversen@aonic.co This information is information that Aonic AB (publ) is obliged to make public pursuant to the Swedish Securities Markets

Terveystalo Group Interim Report January–March 2024: Strong performance driven by improved operational efficiency

Terveystalo Plc, Interim Report 26 April 2024 at 09:00 EEST This release is a summary of Terveystalo's Interim Report January – March 2024. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/company/investors/reports-and-presentations/ January–March 2024 in brief · Revenue increased by 2.7 percent year-on-year to EUR 350.2 (341.1) million.The Healthcare Services segment revenue increased by 7.3 percent and was EUR 268.0 (249.8) million.Portfolio Businesses’ revenue decreased by 8.6 percent and was EUR

Terrafame’s operating result was at a good level in a challenging market

The financial information presented about Terrafame Ltd in this media release consists of unaudited IFRS figures. The figures in brackets refer to the corresponding period in the previous year unless otherwise stated. January−March 2024 in brief: · Net sales were EUR 130.0 (172.7) million, representing a decrease of 24.7% year-on-year. · Net sales from the battery chemicals business decreased to EUR 35.6 (66.2) million, or 27.4% (38.3) of the company’s total net sales. Net sales were negatively affected by a decrease in the market price of nickel sulphate as well as lower

ZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024

Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the meeting to enable remote participation. RIGHT TO PARTICIPATE IN THE COMPANY MEETING Shareholders wishing to attend the annual general meeting must: i. be entered in the shareholder register maintained by Euroclear Sweden AB by Friday, May 17, 2024, and ii. have notified their intention to attend the meeting by Friday, May 24,

There are no items matching the current filter
There are no more items matching the current filter
Back to top